KOSDAQ-listed pharmaceutical firms rose 13 percent in first-quarter profit

Published: 2004-05-21 07:00:00

Updated: 2004-05-21 07:00:00

According to data released by Yakup Shinmoon, the first-quarter profit of 13 KOSDAQ-listed pharmaceutical firms rose 13.6 percent year-on-year to 14.2 billion won on the back of profit-oriented management via sustained shrinkage of general sales & administrative expenses and shortened period of a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK